| Financial Year |
March 31 2023 |
| Monetary Funds |
1,022,253,801.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
253,337,514.08 |
| Advances to Suppliers |
17,488,622.31 |
| Other Receivables |
211,245.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
466,989,569.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,346,604.46 |
| Total Current Assets |
1,913,864,457.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
291,024,956.01 |
| Under-construction Projects |
90,722,133.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
159,108,618.52 |
| R&D expenses |
-- |
| Goodwill |
37,573,929.87 |
| Long-Term Deferred and Prepaid Expenses |
1,864,044.36 |
| Deferred Income Tax Assets |
3,375,947.75 |
| Other Non-Current Assets |
1,862,068.98 |
| Sub-Total of Non-Current Assets |
618,899,609.34 |
| Total Assets |
2,532,764,067.19 |
| Short-Term Loans |
160,819,183.75 |
| Trading Financial liabilities |
-- |
| Notes Payable |
156,474,588.65 |
| Accounts Payable |
115,122,972.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,695,767.22 |
| Taxes Payable |
8,784,038.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,515,965.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,984,508.07 |
| Other Current Liabilities |
882,892.64 |
| Sub-Total of Current Liabilities |
471,071,398.14 |
| Long-term Loans |
14,019,013.51 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,452,965.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
51,164,343.80 |
| Total Liabilities |
522,235,741.94 |
| Paid-In Capital(Or Share Stock) |
133,340,000.00 |
| Capital Surplus |
1,386,628,894.40 |
| Surplus Reserve |
46,130,275.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
419,665,011.59 |
| Minority Stockholder's Interest |
8,965,082.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,001,563,243.25 |
| Owner's Equity（Stockholder's Equity） |
2,010,528,325.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,532,764,067.19 |
